Mast Therapeutics, Inc. 4
4 · Mast Therapeutics, Inc. · Filed Jan 3, 2014
Insider Transaction Report
Form 4
Vetticaden Santosh
Chief Medical Officer & SVP
Transactions
- Award
Employee Stock Option (Right to Buy)
2014-01-02+295,100→ 295,100 totalExercise: $0.47Exp: 2024-01-02→ Common Stock (295,100 underlying)
Footnotes (1)
- [F1]This option has a January 2, 2014 vesting commencement date and vests and becomes exercisable in 48 substantially equal monthly installments over the 48-month period following the vesting commencement date, subject to the reporting person's continued service with the issuer.